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Chronic inflammation has a tight cause-and-effect
relationship with DNA damage by inflicting tissue
damage and increasing cancer risk. Rrm2b, a key
enzyme in de novo deoxyribonucleotide synthesis,
is involved in DNA damage repair, but its role in
cancer development has yet to be demonstrated. In
this work, Rrm2b gene loss led to severe numerical
and structural chromosome abnormalities that
caused ATM activation, inducing p-Ser85 IKKg/
NEMO and IkB kinase (IKK). NF-kB consequently
induced by IKK triggered sustained IL-6 expression
that constitutively activated STAT3 in Rrm2b-defi-
cient cells. High plasma interleukin-6 (IL-6) and asso-
ciated hematologic disorders were observed in
Rrm2b/ mice, and 30%–40% of aged Rrm2b het-
erozygous knockout mice developed plasma cell
neoplasms and suffered from progressive spleno-
megaly and ascites. The genetic ablation of IL-6
suppressed STAT3 induction and delayed disease
onset in Rrm2b/ mice, extending their lifespan.
Thus, Rrm2b plays a crucial role in maintaining chro-
mosomal stability and preventing chronic-inflamma-
tion-associated tumorigenesis.INTRODUCTION
Chronic inflammatory responses disrupt tissue homeostasis and
promote cancer development and progression (Grivennikov
et al., 2010). It was postulated that activated inflammatory cells
serve as a source of reactive oxygen species (ROS) capable of
inducing DNA damage and genomic instability, and, conversely,
DNA damagemay also lead to inflammation and promote tumor-
igenesis (Rodier et al., 2009). Current cancer treatments by radi-
ation therapy or DNA-damaging chemotherapeutic drugs may
result in inflammation that can stimulate tumor growth. Uncover-
ing the molecules that trigger the chronic inflammation associ-
ated with sustained DNA damage response (DDR) signaling
could lead to a deeper understanding of cancer development
and effective strategies for cancer prevention.CDNA damage triggers the DDR in cells through a signal ampli-
fication cascade (Rodier et al., 2009). The DDR in reversible DNA
damage transiently arrests proliferating cells as DNA is repaired.
However, cells with irreparable DNA damage, often caused by
strong genotoxic stresses, present with persistent DNA damage
foci (PDDF) that are detectable by the presence of 53BP1 and
H2AX (Rodier et al., 2009). These cells express a wide range of
chemokines and cytokines (such as interleukin-6 [IL-6], IL-8,
MMP3, and CXCL1), known collectively as the senescence-
associated secretary phenotype (SASP), and are mediated by
ATM but not by senescence regulators. IL-6 and IL-8 corre-
sponding to ATM expression were found in premalignant breast
lesions (Rodier et al., 2009). There is increasing evidence that
DNA damage can lead to inflammation and thereby promote
tumorigenesis. The murine model of hepatocellular carcinoma
was induced by the carcinogen diethylnitrosamine (DEN), in
which DNA damage contributes to necrotic cell death, resulting
in an inflammatory reaction that promoted tumor development
(Maeda et al., 2005). Defective DNA repair caused by a defi-
ciency of the Fen1 exonuclease also results in a tumor-promot-
ing inflammatory response that is driven by damaged DNA
(Zheng et al., 2007).
Ribonucleotide reductase (RR) plays an essential role in sup-
plying deoxyribonucleoside triphosphates (dNTPs) for DNA
synthesis and repair. The RR holoenzyme consists of a heterodi-
meric tetramer of nonidentical homodimers of large Rrm1 (R1)
and small Rrm2 (R2) or Rrm2b (p53R2) subunits (Nordlund and
Reichard, 2006). dNTP is provided by the R1-R2 complex in S
phase. In the G0/G1 phase following DNA-damage stress,
dNTPs for nuclear DNA synthesis and repair are supplied by
Rrm2b (Tanaka et al., 2000). The R1-Rrm2b complex also con-
tributes dNTPs for basal DNA repair andmitochondrial DNA syn-
thesis in quiescent cells without external DNA damage stress
(Bourdon et al., 2007). Despite evidence supporting Rrm2b’s
involvement in DNA damage repair, its role in cancer develop-
ment in vivo is not yet defined.
Rrm2b can also be regulated at the posttranslational level
by ATM during the acute phase of the genotoxic stress response
and is associated with the MRN (NBS1/Rad50/MRE11) complex
(Chang et al., 2008). Our earlier findings linking Rrm2b to ATM
strongly suggested a potential role of Rrm2b in DDR and disease
development. In this study, we investigated this possibility using
Rrm2bknockoutmice.Rrm2bhomozygousknockout (Rrm2b/)
mice did not live long enough for cancer to be observed. Inell Reports 3, 1389–1397, May 30, 2013 ª2013 The Authors 1389
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contrast, Rrm2b heterozygous knockout (Rrm2b+/) mice were
developmentally normal and fertile. Some Rrm2b+/mice devel-
oped chronic inflammation and plasma cell neoplasia after
9months of age and showed signs ofmorbidity. This study shows
that Rrm2b-deficientmice provide an importantmurinemodel for
understanding chronic inflammatory states as well as neoplastic
diseases in the context of persistent DDR signaling and chronic
inflammatory cytokine secretion.
RESULTS
Constitutive NF-kB and STAT3 Mediate Sustained IL-6
Expression in Rrm2b-Deficient Cells
To address whether RRM2b participates in ATM signaling in
response to genotoxic stress, we first compared the activities
of ATM and its downstream substrates between Rrm2b+/+
and Rrm2b/ primary murine embryonic fibroblasts (MEFs)
by immunoblot (IB) analysis. Activated ATM and gH2AX were
more apparent in Rrm2b/ than in Rrm2b+/+ wild-type (WT)
MEFs (Figure 1A). Additionally, a number of ATM/ATR sub-
strates were more highly activated in Rrm2b/ MEFs than in
Rrm2b+/+ MEFs, as determined by an antibody directed against
phosphorylated Ser or Thr residues in the ATM/ATR substrate
motif. ATM and NBS1 protein levels were similar between
Rrm2b+/+ and Rrm2b/ MEFs (Figure 1A). Deletion of Rrm2b
also did not change the protein levels of other RR subunits
(RRM1 and RRM2; Figure S1A). The ATM signaling cascade
can regulate a range of chemokines and cytokines (Rodier
et al., 2009). Therefore, we used multiplex cytokine analysis to
further analyze the cytokine/chemokine profile in culture
medium from Rrm2b+/+ and Rrm2b/ MEFs at passage 2
before and after ionizing radiation (IR) exposure. No significant
difference in cytokine/chemokine levels was observed between
the two cell types, except for IL-6 and monocyte chemoattrac-
tant protein-1 (MCP-1) levels (Figure 1B). Compared with
Rrm2b+/+ MEFs, IL-6 and MCP-1 proteins were already 3-fold
higher in Rrm2b/MEF media prior to IR exposure (Figure 1B).
IL-6 and MCP-1 production in WT cells can be induced by a
high (10 Gy) dose of IR, but not by a low (1 Gy) dose (Figure 1B).
However, production of endogenous IL-6 and MCP-1 by
Rrm2b/MEFs was not further induced by 10 Gy IR, indicatingFigure 1. Sustained IL-6 Expression Mediated by Constitutive NF-kB a
(A) Immunoblotting (IB) analysis of ATM-related signaling proteins in MEFs der
Ser139, g-H2AX; phosphorylated ATM at Ser1981, p-ATM.
(B) IL-6 and MCP-1 cytokines from Rrm2b+/+ and Rrm2b/ MEF media before a
multiplex cytokine assays.
(C) Quantitative RT-PCR (qRT-PCR) analysis of IL-6 and MCP-1 mRNAs of MEF
(D) IB analysis of NF-kB and STAT3 signaling proteins in MEFs from each genot
(E) The IKK kinase activity in MEFs of each genotype was analyzed by in vitro IKK
recombinant protein as a substrate, followed by IB with p-Ser32 IKBa and IKBa
(F) NF-kB and STAT3 DNA-binding activity in MEFs from each genotype analyze
binding activity, which served as a control for extract quality and loading.
(G) qRT-PCR analysis of IL-6 andMCP-1mRNAs inRrm2b/ fibroblasts after infe
examined by IB.
(H) qRT-PCR analysis of IL-6 mRNA in Rrm2b/ MEFs after infection with lentiv
Knocked-down proteins were analyzed by IB and shown in the bottom panels. The
after subtraction from the loading control, which was given an arbitrary value of
Data represented asmean ±SDwere averaged from three independentMEFs der
Figure S1.
Cthat Rrm2b/ MEFs already constitutively secreted both cyto-
kines at maximal levels. Constitutive IL-6 and MCP-1 secretion
also corresponded to high endogenous amounts of IL-6 and
MCP-1 RNA transcripts in Rrm2b/ MEFs (Figure 1C). IL-6
and MCP-1 genes can be regulated by NF-kB, which has
been shown to be a predominant transcription factor in medi-
ating downstream target genes of ATM (Wu et al., 2006). We
next evaluated whether constitutive ATM activity in Rrm2b/
MEFs also altered NF-kB activity. NF-kB activity is modulated
by the inhibitor IKBa, which in turn is negatively regulated by
the IkB kinase (IKK) complex comprised of two catalytic sub-
units, IKKa and IKKb, and the scaffolding protein IKKg/NEMO
(Grivennikov et al., 2010). The levels of IKKa and IKKb as well
as total NF-kB proteins, were similar between Rrm2b+/+ and
Rrm2b/ MEFs, whereas IKKg proteins were slightly elevated
in Rrm2b/ MEFs (Figure 1D). The IKKg/NEMO proteins were
also highly phosphorylated at Ser85, which is known to be
dependent on ATM in response to genotoxic stress (Wu et al.,
2006). Phosphorylated IKKg/NEMO in Rrm2b/ MEFs caused
a 2-fold higher IKK kinase activity compared with Rrm2b+/+
MEFs (Figure 1E). Consequently, IKBa, a repressor of NF-kB
activity, accumulated much less in Rrm2b/ MEFs compared
with WT (Figure 1D). The constitutive DNA-binding activity of
both NF-kB and STAT3 was 2- to 3-fold higher in Rrm2b/
MEFs than in Rrm2b+/+ MEFs (Figure 1F). Messenger RNAs
(mRNAs) of a number of IL-6 downstream target genes, such
as STAT3, c-MYC, and JAGGED1, were correspondingly
elevated in Rrm2b/ MEFs before and after exposure to IR
(Figure S1B). STAT3 protein levels also accumulated more in
Rrm2b/ MEFs than in Rrm2b+/+ MEFs (Figure 1D). Reconsti-
tution of Rrm2b/ fibroblasts with a lentivirus encoding the
Rrm2b gene was able to suppress the expression of IL-6, but
not MCP-1 (Figure 1G). These data suggest that induction
of IL-6 may be a direct consequence of Rrm2b deficiency
or a positive regulatory response to Rrm2b deficiency. ATM
knockdown reduced IL-6 induction by >50% (Figure 1H), and
50%–70% depleted STAT3 was able to reduce IL-6 induction
significantly, by 20%–30%. A significant 30% reduction of
IL-6 can also be achieved by inactivation of NF-kB activity in
Rrm2b/ MEFs with forced expression of adenoviral IkBa
super-repressors (IkBa S32A/S36A; Figure 1H).nd STAT3 in Rrm2b-Deficient Cells
ived from Rrm2b+/+ and Rrm2b/ E14.5 embryos. Phosphorylated H2Ax at
nd after 1 or 10 Gy IR at the indicated time points were analyzed by Luminex
s before and after 1 or 10 Gy IR.
ype.
immunocomplex kinase assay using the IKKg antibodies on GST-IKBa(1-60)
antibodies.
d by a nonradioactive EMSA after quantification and normalization with AP-1
ction with lentiviralRrm2b transgenes. Bottom panel: Transgene proteins were
iruses expressing shRNAs against the indicated target genes or GFP (control).
fold change (Fold) in IB, kinase activity, and EMSAs is relative to theWT control
1.0.
ived from different embryos for each genotype. **p < 0.01; ***p < 0.001. See also
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We also investigated whether the constitutive IL-6 induction
triggered by Rrm2b deficiency could be attributed to senes-
cence. We found that Rrm2b/ MEFs were less senescent
than Rrm2b+/+ MEFs at both low (passage 2) and high (passage
11) passages (Figure S1C). IL-6 and MCP-1 transcription levels
were higher in Rrm2b/ than in Rrm2b+/+ MEFs at passage 2,
whereas p16 and p53 mRNAs were similar between both cell
types (Figure S1D). At passage 11, both IL-6 and MCP-1 RNAs
were significantly elevated in Rrm2b/ MEFs compared with
Rrm2b+/+ MEFs (Figure S1D). IL-6 and MCP-1 RNAs were not
yet induced in high-passage Rrm2b+/+ MEFs despite increased
senescence. Rrm2b/ MEFs also showed increased cyclin D1
proteins (Figure S1F) and demonstrated rapid cellular growth
(Figure S1E). Knockdown of senescence regulator p16 (Fig-
ure S1G) or p53 (Figure S1H) resulted in slightly increased IL-6
inRrm2b/MEFs. Taken together, in the context of Rrm2b defi-
ciency, these results indicate that IL-6 induction through NF-kB
and STAT3 depends on ATMbut not senescence regulators (p16
and p53).
Loss of the Rrm2b Gene Causes Chromosomal
Instability
To directly identify chromosomal abnormalities of any form or
frequency, we analyzed MEFs by spectral karyotype (SKY) anal-
ysis (Figure 2). SKY was performed on MEFs at passage 1 to
minimize the effects of extended cell-culture passaging. The
data indicated that nearly all of the examined chromosomes
from Rrm2b+/+ MEFs had only one break (Figures 2A and 2B).
In addition to chromatid breakage, severe forms of chromosomal
abnormalities, including deletion, loss, and translocation, were
identified in Rrm2b haploinsufficient (Rrm2b+/) MEFs. Deletion
of both Rrm2b alleles created additional chromosomal abnor-
malities, including gains, duplications, and isochromosomes
(Figures 2A and 2B). The total spontaneous aberrations from
each chromosome in Rrm2b/ MEFs were almost 100-fold
and 5-fold higher compared with Rrm2b+/+ and Rrm2b+/
MEFs, respectively (Figure 2A). After exposure to 1 Gy IR, addi-
tional forms of chromosomal abnormalities (derivative and
dicentric chromosomes) were observed in Rrm2b/ MEFs,
whereas chromatid breakage was the only type of abnormality
found in Rrm2b+/+ MEFs (Figure 2C). Excluding chromatid
breakage, there was an almost 300-fold increase in IR-induced
chromosomal aberration frequencies in Rrm2b/ MEFs com-
pared with Rrm2b+/+ MEFs (Figure 2A). These results demon-
strate that Rrm2b is involved in preserving the integrity of
chromosomal number and structure, thereby helping to maintain
genetic stability. The same batch of MEFs that were analyzed for
genetic abnormality (Figure 2) were also analyzed for DDRFigure 2. Increased Numerical and Structural Chromosome Abnormal
(A) The values in the table represent the number of each different type of aberrant
lines before and 24 hr after 1 Gy IR for each genotype analyzed by fluorescen
aberration frequencies, excluding chromatid breakage, among the genotypes is
copies of chromosomes; loss, missing copies of chromosomes; der, derivative ch
centromeres; isochromosome, fusion of chromosomes.
(B and C) Representative pseudocolor spectral karyotype image of one MEF f
t, translocation; dic, dicentric.
Data are represented as mean ± SD. ***p < 0.001. See also Figure S2.
Csignaling and IL-6 expression at a single-cell level by immunocy-
tochemistry (ICC; Figure S2). Compared with Rrm2b+/+ MEFs,
Rrm2b/ MEFs showed more robust IL-6, p-ATM, and gH2AX
signals (compare Figures S2A, S2B, S2D, S2E, S2G, and S2H).
Distinct nuclear p53 binding protein-1 (53BP1) foci formation
accumulated robustly in Rrm2b/ MEFs (compare Figures
S2Jand S2K). IL-6, p-ATM, gH2AX, and 53BP-1 signals in
Rrm2b+/+ MEFs were low prior to IR but higher following expo-
sure to 4 Gy IR (Figures S2C, S2F, S2I, and S2L). Nuclear
Rrm2b expression in Rrm2b+/+ MEFs (Figure S2M) appeared
to be specific, as it was completely absent in Rrm2b/ MEFs
(Figure 2N).
Mice Deficient in Rrm2b Exhibit Elevated IL-6 and
Hematologic Disorders
Next, we assessed whether loss of the Rrm2b gene can cause a
change of IL-6 andMCP-1 expression in mice tissue. Loss of the
Rrm2b gene resulted in a dose-dependent effect on IL-6 gene in-
duction in bonemarrows (Figure 3A). IL-6 RNA levels were 4-fold
higher in Rrm2b/ bone marrows than in Rrm2b+/+ bone
marrows, whereas IL-6 levels in Rrm2b+/ bone marrows were
intermediate between those of the two genotypes (Figure 3A).
Similar outcomes were observed in 1-month-old mice blood,
where the loss of one or both Rrm2b genes corresponded to in-
creases in serum IL-6 andMCP-1 protein levels in a dose-depen-
dent manner (Figure 3B). Accumulation of MCP-1 and especially
IL-6 continued in 9- to 12-month-old Rrm2b+/ mice, but not in
age-matched Rrm2b+/+ littermates (Figure 3C). Unfortunately,
Rrm2b/ mice did not survive longer than 7 weeks after birth.
Beginning at 7 months, some Rrm2b+/ mice developed
severely hemorrhagic splenomegalies (Figure 3D). Therefore,
we monitored various organ weights and the total body weight
of 7- to 9-month-old Rrm2b+/+ and Rrm2b+/ mice, and found
that spleens from Rrm2b+/ mice were substantially and signifi-
cantly larger than those from Rrm2b+/+ mice, whereas other
organs were comparable in size and weight (Figure S3A). The
liver was slightly enlarged in Rrm2b+/ mice as compared with
their normal counterparts, but the difference between the two
genotypeswas insignificant (Figure S3A). Histologic examination
of Rrm2b+/ spleen sections at different ages also showed signs
of progressive pathology. The white pulps of Rrm2b+/ and
Rrm2b/ spleens were larger and more numerous compared
with those of Rrm2b+/+ spleens at 1 month of age (Figure 3E).
At 12 months, the architecture of Rrm2b+/ spleens appeared
remarkably disorganized, as the marginal zones disappeared
and the red and white pulps became indistinguishable (Fig-
ure 3F). Clusters of CD138+ (a plasma cell marker) plasmacytoid
infiltrate were also observed in Rrm2b+/ spleens (Figure 3G).ities in Rrm2b-Deficient Cells
chromosomes in the examined total chromosomes from three independent cell
ce in situ hybridization karyotype analysis. The fold change of chromosome
shown in the histograms. Chtb, chromatid breakage; del, deletion; gain, extra
romosome; dup, duplicated chromosome; dicentric, chromosomes having two
rom each genotype before (B) and 24 hr after (C) 1 Gy IR. +, gain; , loss;
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Figure 3. Elevated IL-6 and MCP-1 and the Plasma Cell Neoplasia Phenotype in Aged Rrm2b+/ Mice
(A) IL-6 and MCP-1 mRNAs in 1-month-old bone marrows from each genotype analyzed by qPCR.
(B and C) IL-6 and MCP-1 protein levels from blood serum of 1-month-old (B) and 9- to 12-month-old (C) mice.
(D) Spleens from each genotype at the indicated ages. The data shown were obtained from a litter-matched group of mice.
(E) Tiling images of representative H&E-stained sections of spleen from each genotype at 1 and 12 months.
(F) Higher magnification of the boxed area of 12-month-old spleens. MG, marginal zone; RP, red pulp; WP, white pulp.
(G) Representative section of immunohistochemistry (IHC) staining for CD138, kappa light chain, and lambda light chain antibodies (brown color) from 12-month-
old Rrm2b+/+ and Rrm2b+/ spleens.
(H) Fluorescence-activated cell sorting of cells derived from Rrm2b+/+ and Rrm2b+/ primary bone marrows for plasma cells using CD138 and B220 antibodies.
(I) CBC of peripheral blood from 12-month-old mice. HBG, hemoglobin; PLT, platelet; RBC, red blood cell; WBC, white blood cell.
Data are represented as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S3.These compactly arranged plasmacytoid cells appeared to be
monoclonal, and selectively expressed the immunoglobulin (Ig)
kappa light chain but not the lambda light chain (Figure 3G).
Furthermore, plasma cell numbers were >5-fold higher in
Rrm2b+/ than in Rrm2b+/+ bone marrows (Figure 3H). In
contrast, <1% of Rrm2b+/ expressed B220, a marker of early
pro-B cells, whereas 15% of the Rrm2b+/+ bone marrow pop-
ulation were B220 positive (Figure 3H). These results indicated
that most of the populations of B cells in aged Rrm2b+/ mice
were plasma cells. An elevated plasma cell count should lead1394 Cell Reports 3, 1389–1397, May 30, 2013 ª2013 The Authorsto an abnormal amount of antibody production. As expected,
abnormal Ig levels were found in mice deficient in the Rrm2b
gene (Figure S3). IgA and IgE levels were similar in young and
old mice regardless of genotype (Figures S3B and S3C). How-
ever, in younger mice, IgM levels increased and IgG levels
decreased significantly with loss of the Rrm2b gene in a dose-
dependent manner (Figures S3D and S3E). Serum IgG levels
were nearly undetectable in Rrm2b/ mice (Figure S3E). With
age, Rrm2b+/ mice developed significantly higher serum
IgM levels than age-matched Rrm2b+/+ mice (Figure S3D).
Conversely, IgG levels were significantly lower in aged Rrm2b+/
mice compared with Rrm2b+/+ mice (Figure S3E). Defective B
cell development and abnormal serum Ig levels in Rrm2b-defi-
cient mice prompted us to analyze the complete blood count
(CBC) profiles of these mice. Significantly higher levels of white
blood cells (WBCs), lymphocytes, and neutrophils were found
in 1-month-old Rrm2b/ mice compared with their Rrm2b+/+
littermates (Figure S3F). The cell counts of Rrm2b+/ mice
were intermediate between those of their Rrm2b/ and
Rrm2b+/+ littermates, indicating an Rrm2b gene dose-depen-
dent effect on the development of blood cell lineages. Aged
and sick Rrm2b+/ mice developed even more significantly
elevated levels of WBC and lymphocyte counts than their WT
littermates (Figure 3I). Some Rrm2b+/ mice also presented
with hair loss, skin infections, and enlarged lymphoid nodes (Fig-
ures S3H, S3J, and S3L). Some of the sick Rrm2b+/ mice even
had a ruptured spleen and liver and developed ascites at close to
12 months of age (Figure S3M). Abnormally high monoclonal
plasma cells, Ig levels, andWBCcounts are hallmarks of patients
suffering from plasma cell neoplasms, including multiple
myeloma (MM) and plasmacytoma (Naugler and Karin, 2008).
Effect of Crossing Rrm2b/ Mice with IL-6-Deleted
Mice
The observation that IL-6 production was increased in Rrm2b-
deficient cells and mice led us to investigate the contribution
of this cytokine to disease in Rrm2b/ mice. Rrm2b+/ and
IL-6+/ heterozygote mice were crossed to generate Rrm2b/
IL-6/ double mutants. Hemorrhaging was not apparent in
1-month-old Rrm2b/IL-6/ and 11-month-old Rrm2b+/IL-
6/ spleens (Figure 4A). Abnormal IgM (Figure S4A) and IgG
(Figure S4B) levels in Rrm2b+/ and Rrm2b/ mice were
restored to a range similar to that observed in Rrm2b+/+ litter-
mates after IL-6 deletion. The CBC profiles of the Rrm2b/IL-
6/ andRrm2b+/IL-6/micewere also similar to those of their
WT littermates (Figures S4C and S4D). Elevated STAT3 (89 kDa)
proteins and phosphorylation (Ser727) levels (Figure 4B), as well
as mRNAs of IL-6 downstream genes (STAT3, c-Myc, Notch,
and Jagged 1; Figure 4C), in oldRrm2b+/IL-6/ bonemarrows,
were suppressed following IL-6 deletion. The removal of IL-6
dramatically reduced urine protein secretion and glomerulop-
athy (Figures 4D and S4E). Despite extensive genomic abnor-
malities in Rrm2b/MEFs, elimination of the IL-6 gene was still
able to extend the life of Rrm2b/ mice by 8–10 weeks (Fig-
ure 4E). Mortality in Rrm2b+/IL-6/ mice was undetectable at
9–14 months, compared to 30%–40% mortality in Rrm2b+/IL-
6+/+ mice of the same age (Figure 4E). Most importantly, bone
marrow myeloma cells of MM patients (n = 41) showed a signif-
icant 3-fold decrease in Rrm2b and 5-fold increase in IL-6
expression compared with normal human bone marrows.
Rrm2b levels correlated inversely with IL-6 expression in MM
patients (Pearson’s correlation coefficient, r = 0.9014).
DISCUSSION
DNA damage caused by depleted dNTP pools can trigger an
ATM-Chk2-like S phase checkpoint pathway (Kumar et al.,
2011). Elevated ATM activity induced by attenuated dNTP poolsCin Rrm2b-deficient MEFs may serve as a genome surveillance
mechanism. In addition to orchestrating cell-cycle checkpoints,
ATM stimulates the secretion of proinflammatory cytokines
induced by irreparable DNA damage (Rodier et al., 2009). Chro-
mosomal abnormalities in Rrm2b-deficient MEFs (Figure 2)
could have led to irreparable DNA damage and constitutive
DDR signaling, resulting in the autonomous secretion of cyto-
kines, including IL-6 andMCP-1 (Figure 1). Our data confirm pre-
vious findings that persistent DDR-induced IL-6 mRNA in
Rrm2b/MEFs can be suppressed by >50% by a small hairpin
RNA (shRNA) against ATM (Figure 1). Rrm2b was previously
shown to be associated with ATM and theMRN complex (Chang
et al., 2008). In addition to supplying dNTPs, Rrm2bmay interact
with ATM and the MRN complex to maintain chromatin stability.
Therefore, constitutive ATM activation by Rrm2b deficiency may
potentially be attributed to a mechanism that is independent of
dNTP depletion.
NF-kB and STAT3 are central signaling hubs in regulating
inflammation-mediated tumor promotion and metastasis (Gri-
vennikov et al., 2010). Cooperative signaling through the
NF-kB and STAT3 pathways has been found in numerous
cancers. Activated NF-kB and STAT3 can synergistically or indi-
vidually control the expression of antiapoptotic, proproliferative,
and proinflammatory cytokine genes (albeit through different
mechanisms) to promote tumorigenesis. IL-6 has been impli-
cated as a potential mediator between NF-kB and STAT3 (Gri-
vennikov and Karin, 2008). Here we demonstrate that aberrant
activation of NF-kB induced by ATM-IKK led to the stimulation
of STAT3 and consequent release of IL-6, providing evidence
of a crosstalk between NF-kB and STAT3 signaling in the con-
text of genome instability triggered by Rrm2b deficiency. The
interplay between NF-kB and STAT3 might make it difficult to
completely blunt IL-6 induction by merely disrupting either
NF-kB or STAT3 signaling (Figure 1H).
IL-6, a multifunctional proinflammatory cytokine, is involved in
cell survival, apoptosis, proliferation, immune responses, and
tumorigenesis (Naugler and Karin, 2008). The role of IL-6 in carci-
nogenesis is especially pronounced in MM, a neoplasm of
plasma cells. Renal failure is a major cause of mortality in MM
patients. Similarly to previous observations (Kimura et al.,
2003; Powell et al., 2005), we also observed that severe kidney
failure with marked proteinuria was a primary cause of death
(Figure S4E). We found that, in addition to onset of kidney failure,
Rrm2b/ mice developed dysfunctional immunologic and he-
matopoietic systems (i.e., high serum IL-6, splenic hemorrhage,
abnormal IgM and IgG levels, lymphocytosis, neutrophilia, and
thrombocytosis). Furthermore, some aged Rrm2b+/ mice
developed a plasmacytoma-like neoplasm, progressive spleno-
megaly, enlarged lymph nodes, and ascites. Blockade or modu-
lation of the IL-6 signal is a strategy that is well on its way to
clinical trials for lymphoma, MM, and chronic inflammatory dis-
eases (Naugler and Karin, 2008). Interestingly, Rrm2b/IL-
6/mice lived 2 months longer than Rrm2b/mice (Figure 4E).
Splenic hemorrhage, abnormal hematologic parameters, and
proteinuria were dramatically reduced in Rrm2b/IL-6/ dou-
ble mutants (Figure 4). Kidney and spleen samples from both
Rrm2b/IL-6/ mice and their age-matched WT littermates
showed no pathologic findings. These results strongly suggestell Reports 3, 1389–1397, May 30, 2013 ª2013 The Authors 1395
Figure 4. IL-6 Deficiency Delayed Disease Onset and Mortality of Rrm2b/ Mice
(A) Absence of splenic hemorrhage in a representative 1-month-old Rrm2b/IL-6/ spleen and 11-month-old Rrm2b+/IL-6/ spleen compared with spleens
from age-matched littermates.
(B) Analysis of STAT3 activity and protein expression in 12-month-old bone marrows from the indicated genotypes by IB analysis using antibodies against
phospho-STAT3 (Ser727) and STAT3.
(C) mRNA levels of the indicated genes in 12-month-old bone marrows from the indicated genotypes.
(D) Deletion of IL-6 blocked urinary protein secretion in Rrm2b/ mice at 5 weeks of age.
(E) Kaplan-Meier survival curve for mice of the indicated genotypes.
(F) Representative section of IHC staining for Rrm2b and IL-6 antibodies (brown color) from normal human bone marrows and myeloma cells from anMM patient
(n = 41). Nuclear Rrm2b is indicated by arrowheads. Quantification of Rrm2b and IL-6 signals is shown in the histogram. The correlation between relative IL-6 and
Rrm2b levels in MM patients was plotted and analyzed by Pearson correlation coefficient analyses (r denotes Pearson’s correlation).
Data are represented as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. See also Figure S4.
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that IL-6 partly contributes to the development of hematologic
disorders and mortality from renal failure in Rrm2b/ mice.
Our findings demonstrate a potential role of Rrm2b in prohib-
iting oncogenesis. Earlier data suggested that RRM2B protein
levels might be negatively correlated with cancer progression
(Liu et al., 2011; Zhang et al., 2011). Based on the observed phe-
notypes in the Rrm2b-deficient mice model, we conclude that
Rrm2b deficiency may be a potential risk factor for hematologic
malignancy. Indeed, RRM2B proteins were much reduced in
myeloma cells of MM patients (Figure 4F). Rrm2b deletion,
mutation, or haploinsufficiency can serve as a diagnostic marker
in MM or other lymphomas. Finally, Rrm2b reduction could
potentially be used in personalized medicine to identify patients
who are susceptible to the inflammatory side effects and cancer
risk of traditional radiation therapy or DNA-damaging chemo-
therapeutic drugs.
EXPERIMENTAL PROCEDURES
Mice, Cell Culture, and Human Specimens
Generation of Rrm2b/ mice by the gene trap method has been described
previously (Powell et al., 2005). Rrm2b+/ mice in mixed genetic background
(129/SvEvBrd and C57BL/6J) were obtained from the Texas A&M Institute
for Genomic Medicine (TIGM) and backcrossed to C57BL/6J mice for 7 gen-
erations. IL-6/ mice (stock number: 002650, C57BL/6J background) were
purchased from The Jackson Laboratory. Marine studies were carried out in
accordance with protocols approved by the Institutional Animal Care and
Use Committee of City of Hope. In vitro Miffs experiments used the mice
that have been had been backcrossed to C57BL/6 for at least 7 generations,
except for Rrm2b/ fibroblasts (Figure 1F), which were derived from mouse
embryos in mixed sv129 and C57BL/6 background (Tanaka et al., 2000).
MM specimens (IRB10046) were obtained from the tissue bank of Transla-
tional Research (TLR) Core at City of Hope. The use of archival human cancer
specimens was approved by the Cancer Protocol Review and Monitoring
Committee of City of Hope in compliance with the Public Health Service
policies of the United States. For further details regarding the materials and
methods used in this work, see Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
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four figures and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2013.03.040.
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